全文获取类型
收费全文 | 3779篇 |
免费 | 297篇 |
国内免费 | 118篇 |
专业分类
耳鼻咽喉 | 55篇 |
儿科学 | 174篇 |
妇产科学 | 40篇 |
基础医学 | 202篇 |
口腔科学 | 190篇 |
临床医学 | 388篇 |
内科学 | 910篇 |
皮肤病学 | 10篇 |
神经病学 | 74篇 |
特种医学 | 90篇 |
外科学 | 422篇 |
综合类 | 381篇 |
现状与发展 | 2篇 |
预防医学 | 173篇 |
眼科学 | 51篇 |
药学 | 541篇 |
3篇 | |
中国医学 | 84篇 |
肿瘤学 | 404篇 |
出版年
2024年 | 16篇 |
2023年 | 79篇 |
2022年 | 149篇 |
2021年 | 263篇 |
2020年 | 169篇 |
2019年 | 162篇 |
2018年 | 166篇 |
2017年 | 128篇 |
2016年 | 122篇 |
2015年 | 111篇 |
2014年 | 240篇 |
2013年 | 241篇 |
2012年 | 194篇 |
2011年 | 207篇 |
2010年 | 188篇 |
2009年 | 181篇 |
2008年 | 170篇 |
2007年 | 172篇 |
2006年 | 155篇 |
2005年 | 139篇 |
2004年 | 127篇 |
2003年 | 95篇 |
2002年 | 99篇 |
2001年 | 72篇 |
2000年 | 54篇 |
1999年 | 71篇 |
1998年 | 53篇 |
1997年 | 53篇 |
1996年 | 40篇 |
1995年 | 55篇 |
1994年 | 34篇 |
1993年 | 23篇 |
1992年 | 22篇 |
1991年 | 23篇 |
1990年 | 9篇 |
1989年 | 15篇 |
1988年 | 14篇 |
1987年 | 11篇 |
1986年 | 7篇 |
1985年 | 9篇 |
1984年 | 7篇 |
1983年 | 8篇 |
1982年 | 11篇 |
1981年 | 8篇 |
1980年 | 3篇 |
1978年 | 6篇 |
1977年 | 4篇 |
1974年 | 2篇 |
1968年 | 1篇 |
1966年 | 1篇 |
排序方式: 共有4194条查询结果,搜索用时 15 毫秒
71.
Flow cytometry minimal residual disease after allogeneic transplant for chronic lymphocytic leukemia
下载免费PDF全文
![点击此处可从《European journal of haematology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Caroline Algrin Jean‐Louis Golmard Mauricette Michallet Oumedaly Reman Anne Huynh Aurore Perrot Anne Sirvent Adriana Plesa Véronique Salaun Marie‐Christine Béné Dominique Bories Olivier Tournilhac Hélène Merle‐Béral Véronique Leblond Magali Le Garff‐Tavernier Nathalie Dhedin 《European journal of haematology》2017,98(4):363-370
72.
73.
《Expert review of cardiovascular therapy》2013,11(5):871-880
Obstructive lesions in the aortic arch are comprised of discrete coarctation, tubular hypoplasia and interruption. This review discusses the anatomy of the lesions relevant to interventional treatment. Catheter intervention, using not only balloon angioplasty but also stent implantation for coarctation, has been developed over the past couple of decades as an alternative treatment to surgery. Several studies have reported long-term outcome and the benefits of surgery and catheter intervention for treating obstructive lesions in the aortic arch but more studies are needed for comparable evaluations. The development of imaging and further improvement of surgical and catheter intervention, such as hybrid intervention or new devices, will help in removing the obstruction safely. 相似文献
74.
Colorectal cancer is the second leading cause of cancer death in the United States for men and women, with an estimated 146,000 new cases per year - a staggering 53,000 patients die each year. Rectal cancer comprises a third of these patients, with a 5-year survival rate of 67%. Management of locally advanced rectal cancer in the U.S. had remained stagnant for more than a decade, with most of these patients being treated with long-course chemoradiotherapy, surgery, followed by adjuvant chemotherapy; adjuvant chemotherapy being administered despite lacking a high level of evidence. Over the past few years, with rectal cancer death rates exceeding 30% from metastatic disease, growing interest focused on the attributes of induction chemotherapy to eradicate minimal residual disease and purportedly increase survival. This led to the development of total neoadjuvant therapy (TNT). We now have high-quality data from randomized prospective trials to review the facts, fantasies, and fallacies of TNT. 相似文献
75.
We characterized 168 junctional regions of T-cell receptor delta (TCRD) rearrangements from 116 children with acute lymphoblastic leukemia (ALL) (101 with precursor B-cell ALL, 15 with T-cell ALL). Application of 101 allele-specific oligonucleotide (ASO) probes representing 85 Vdelta2Ddelta3, 10 Ddelta2Ddelta3, 3 Vdelta1Jdelta1, 1 Vdelta3Jdelta1, and 2 Ddelta2Jdelta1 junctions for the detection of minimal residual disease (MRD) revealed detection levels of 10(-4) to 10(-6) leukemia cells in the vast majority of cases (93 of 101). Of interest was that neither the N, D, P (nontemplated, diversity, palindromic) content and length of the junctional regions nor the number of nucleotides deleted from the flanking V, D, or J (variable, diversity, joining) elements correlated with the sensitivity of ASO probes. These data indicated that in ALL TCRD rearrangements can serve as suitable tools for the detection of MRD irrespective of the specific composition of the junctional region. 相似文献
76.
Immunophenotype of c-kit cells in normal human bone marrow: implications for the detection of minimal residual disease in AML 总被引:3,自引:0,他引:3
A. Macedo A. Orfao † A. Martianez M. B. Vidriales B. Valverde M. C. Loapez-Berges J. F. San Miguel 《British journal of haematology》1995,89(2):338-341
Summary. In the present study, seven normal human bone marrow samples from healthy volunteers have been analysed in order to investigate the immunophenotypic characteristics of the normal CD117+ cells and their utility for the detection of minimal residual disease in 71 acute myeloid leukaemia patients.
Our results show that most of normal BM CD117+ cells coexpress the HLADR and the myeloid associated CD33 antigen. In addition, almost half of CD117+ cells are CD34+ , these cells displaying a different FSC/SSC distribution when compared to the CD117+ /CD34− cells. No CD117+ /CD15+ and CD117+ /CD10+ cells were detected and very few CD117+ cells (<1 × 10−3 ) expressing the HLADR− /CD34− , CD33+ /HLADR− and CD34+ /HLADR− phenotypes were found to be present in normal BM. In contrast, from the 71 AML patients analysed, 34 had CD117+ /CD15+ blast cells and eight had the CD117+ phenotypes detected at low frequencies (<1 × 10−3 ) in normal BM.
In summary, the present study shows that the use of the CD117 antigen in different monoclonal antibodies combinations may be of great help for the detection of minimal residual disease in a high proportion of AML cases, especially in those patients displaying the CD117+ /CD15+ phenotype, because cells coexpressing both antigens in normal BM, if present, are at very low frequencies. 相似文献
Our results show that most of normal BM CD117
In summary, the present study shows that the use of the CD117 antigen in different monoclonal antibodies combinations may be of great help for the detection of minimal residual disease in a high proportion of AML cases, especially in those patients displaying the CD117
77.
Detection of minimal residual disease in B-lineage acute lymphoblastic leukaemia by quantitative flow cytometry 总被引:5,自引:0,他引:5
Nahla Farahat Alison Morilla Kwasi Owusu-Ankomah Ricardo Morilla C. Ross Pinkerton Jennie G. Treleaven Estella Matutes Ray L. Powles & Daniel Catovsky 《British journal of haematology》1998,101(1):158-164
The clinical significance of detecting minimal residual disease (MRD) in B-lineage acute lymphoblastic leukaemia (ALL) was evaluated by quantitative flow cytometry using a combination of TdT with CD10 and CD19. 53 patients with B-cell precursor ALL were followed during and after completion of treatment (median follow-up 23 months). Nine patients relapsed and MRD had been detected in six of them, 5–15 weeks before relapse despite morphological complete remission. 43 patients remain in clinical remission and in none of these was MRD detected. Disease-free survival based on the detection of MRD by flow cytometry showed a statistically significant difference between both groups ( P < 0.0001). The absence of MRD correlates with a low relapse rate, whereas the presence of MRD predicted early relapse. This study has shown that flow cytometry can improve the morphologic assessment of bone marrow (BM) remission status in B-lineage ALL. The finding of < 5% blasts in BM aspirates did not correlate with 'true' remission in a proportion of cases as residual leukaemic blasts were detected by flow cytometry in nine samples from six patients. On the other hand, the presence of > 5% blasts assessed by morphology was not necessarily a feature of relapse in five patients as these cells were shown to have a phenotype identical to normal TdT-negative B-cell precursors. Quantitative flow cytometry was more informative than conventional morphology to assess remission status and showed a strong correlation with clinical outcome. This methodology is useful to define MRD in the majority of patients with B-lineage ALL and should be tested in prospective clinical trials. 相似文献
78.
Outcome prediction by immunophenotypic minimal residual disease detection in adult T-cell acute lymphoblastic leukaemia 总被引:2,自引:0,他引:2
Krampera M Vitale A Vincenzi C Perbellini O Guarini A Annino L Todeschini G Camera A Fabbiano F Fioritoni G Nobile F Szydlo R Mandelli F Foà R Pizzolo G 《British journal of haematology》2003,120(1):74-79
Flow-cytometric detection of minimal residual disease (MRD) identifies patients with high relapse risk in childhood acute lymphoblastic leukaemia (ALL). We studied the efficacy of this method in adult T-ALL treated with the Italian co-operative GIMEMA (Gruppo Italiano Malattie Ematologiche dell'Adulto) LAL0496 protocol. Bone marrow samples from 53 patients were taken at fixed treatment time points and MRD was analysed using a leukaemia-specific immunophenotype (cytoplasmic-CD3/nuclear-terminal desoxynucleotidyl transferase). The median follow-up was 17 months (range 3-61) and a median of 4.5 analyses/patient was performed (range 3-12). Six out of 53 (11.3%) patients were refractory to treatment, 30/53 (56.6%) relapsed and 17/53 (32.1%) remain in continuous complete remission. The probability of relapse at 2 years for MRD-positive patients at preconsolidation was 81.5%vs 38.9% for MRD-negative patients (P = 0.00078). This risk was still 54.5% for MRD-positive vs 15.8% for MRD-negative patients pre-third reinduction (P = 0.0098) and 50.0% for MRD-positive vs 16.4% for MRD-negative patients pre-sixth reinduction (P = 0.032). The relapse-predicting value of MRD did not depend on features at diagnosis such as age, sex and leucocyte count. Our data suggest that immunophenotypic MRD monitoring in the first year of treatment is a useful outcome predictor for adult T-ALL patients. 相似文献
79.
Complementarity determining region-III is a useful molecular marker for the evaluation of minimal residual disease in mantle cell lymphoma 总被引:1,自引:0,他引:1
Toshiro Kurokawa Tomohiro Kinoshita Takashi Murate Tetsuro Nagasaka Yoshitoyo Kagami Michinori Ogura Shigeo Nakamura Masao Seto Tomomitsu Hotta & Hidehiko Saito 《British journal of haematology》1997,98(2):408-412
Bone marrow (BM) and peripheral blood (PB) involvement in 10 patients with mantle cell lymphoma (MCL) was analysed by a polymerase chain reaction (PCR)-mediated RNase protection assay. The complementarity determining regions (CDR)-III of all 10 MCLs examined was amplified efficiently with consensus VH and JH primers by PCR, and BM and/or PB involvement was evaluated by RNase protection assay in all 10 patients examined. Our assay showed BM and/or PB of the entire group to have neoplastic cells at presentation, despite the fact that eight patients were found to have BM and/or PB involvement on the basis of morphological examination and/or surface marker analysis. We also examined minimal residual disease (MRD) after conventional chemotherapy, and detected MRD in a patient in complete remission (CR). Although previous studies have shown that t(11;14) breakpoint amplification by PCR was only applicable to about 30–40% of cases, the present study indicates that CDR-III is a useful molecular marker and the PCR-mediated RNase protection assay is a good tool for the evaluation of MRD in MCL. It is suggested that BM and PB of MCL patients are quite frequently involved at presentation and even after conventional chemotherapy at the molecular level. 相似文献
80.